Showing posts with label MEDICAL MARIJUANA. Show all posts
Showing posts with label MEDICAL MARIJUANA. Show all posts

Wednesday, November 15, 2017


Medical Marijuana

This week Las Vegas is hosting the world’s largest gathering of cannabis executives, exhibitors, and innovators. The Fall 2017 installation of the Marijuana Business Conference and Expo, taking place this week from November 14-17, 2017 at the Las Vegas Convention Center in Las Vegas, Nevada, is the place to discuss the latest trends in the multi-billion dollar global cannabis industry.

CEO of Premium Produce Priscilla Vilchis, the only female minority with two cannabis licenses in Las Vegas and three in Los Angeles County, California, will be speaking on the “Cultivation Data Download: Stats, Trends & Analysis” panel on Friday, November 17 from 11:30 a.m. to 12:20 p.m. She will be presenting alongside other marijuana executives on a number of topics, including the range of costs required to start and operate various types of growing operations; tips to increase yield and maximize revenue; how cultivators are adapting to falling wholesale marijuana prices; and strategies to implement new lighting technologies into your grow facility.

Dr. Stuart Titus, CEO of Medical Marijuana, Inc., spoke on two panels at MJBizCon. The “International Developments & Opportunities” panel took place from 2:30-3:00 p.m. on November 14. This panel provided an insight into the current state of international developments pertaining to cannabis. The “Q&A with Hemp Experts” panel took place from 3:45-4:45 p.m. on November 14, which will be an interactive experience in which audience members will be able to present hemp industry experts with their questions.

Cannabis commercial real estate executive Tim Mcgraw, CEO of Canna-Hub, will be available to discuss how cannabis is an attractive real estate investment, and why the future of cannabis cultivation will be led by some of the country’s most sophisticated.

Monday, March 30, 2015



New York State Senator Daniel Squadron and Assembly Member Robert J. Rodriguez have reintroduced S. 137 & A. 6218, the "Fairness and Equity Act" ("FEA"), a comprehensive piece of legislation that would expand the decriminalization of cannabis in New York State. Enacting the FEA would not only put an end to the racially biased practice of arresting mostly young men of color for criminal possession of cannabis, it would also establish a procedure for people previously convicted of certain cannabis crimes to vacate their judgments.

The collateral damage of being convicted of a cannabis crime can be life altering, including the loss of financial aid for students, exclusion from low income housing, deportation and adverse consequences for future employment. Under state law, the possession of up to 25 grams of cannabis in private is a civil violation, punishable by a maximum of a $100 fine. By contrast, the possession of any amount of cannabis that is burning or in public view is classified as a criminal misdemeanor [NY State Penal Law 221.10]. The FEA would redefine criminal possession of cannabis to amounts greater than 25 grams.

In 2013, New York State spent between $36 million and $72 million arresting approximately 36,000 people for criminal possession of marijuana in the fifth degree. Many of these arrestees had marijuana on their person, and only revealed the cannabis publicly after being ordered by police to empty their pockets during 'stop-and-frisk' searches. According to the Governor's office, 94 percent of arrests for small amounts of marijuana in the state are in New York City. Over 85 percent of those charged were either African American or Latino.

The FEA is the next step in our fight to end cannabis prohibition in New York State. By further decriminalizing cannabis, we will be paving the way for other important legislation, such as the Marihuana Regulation and Taxation Act. Please help us put greater checks and balances on unjust and discriminatory police practices throughout our state by further decriminalizing cannabis.

EDITORS NOTE: This was sent to us by NORML. We think it is crazy to continue to arrest and spend this kind of money for smoking Marijuana. It is time we wake up and for once New York State politicians need to do something the people of this state want.Tax it and make money for the state, stop spending money on these arrests and stop jailing people who enjoy a good smoke, just like other people enjoy a good drink.

Monday, June 23, 2014


Andrew Cuomo

Gov. Andrew Cuomo has just done a huge dis-service to New Yorkers. I like the guy, I like his family, but am very disappointed.

The state Senate passed a bill that would limit consumption to edibles, pills, and oils—prohibiting the smoking or sale of actual marijuana plants. Gov. The bill passed the Senate 49 to 10 after state leaders announced a legislative compromise.

Everyone bowed down to the drug companies. Having had my own health issues a few years ago, I was prescribed Marinol Pills, which is Marijuana in pill form. They did nothing to help, and they cost over 2 thousand dollars for a month prescription. I am sure by now they are over 3 grand a month.

What Gov. Cuomo has done by demanding this compromise, was continue to allow arrest of innocent people and allowed the black market to continue in the Marijuana trade. New York State would have collected billions, once the whole system was in place for a couple of years. New York State would have saved billions from not arresting and jailing Marijuana users. It was a win-win for New Yorkers. Our lawmakers and our Governor have failed us. Now the doors are open for the big drug companies to produce useless Marijuana pills and edibles, that cost thousands and do nothing. I can not wait for the first drug company to open up a bakery for Marijuana edibles in Manhattan. 

Our elected officials need to re-visit this. Every arrest and every prescription will cost the taxpayers billions that could be used on education, infrastructure and other things. I adore Andrew Cuomo, but this was a huge mistake. Our elected officials need to wake up and do what the people of New York State want.

Thursday, March 28, 2013



Richard N. Gottfried

Patients suffering from severe debilitating or life-threatening conditions could be treated with medical marijuana under medical supervision under a bill introduced by key legislators today. Eighteen states and the District of Columbia have laws that allow medical use of marijuana.
New York's bill A. 6357/ S. 4406, introduced by Assembly Health Committee Chair Richard N. Gottfried and Senator Diane J. Savino, is co-sponsored by 68 other legislators. The bill passed the Assembly by a vote of 91-52 last year.

"If the patient and physician agree that the patient's severe debilitating or life-threatening condition should be treated with medical marijuana, the government should not stand in the way," said Gottfried. "It is cruel to deny treatment to patients who are suffering or to turn them into criminals."

"Thousands of New Yorkers have serious medical conditions that would benefit from medical use of marijuana," Senator Savino said. "Anybody who ever had a family member suffer from a debilitating disease learns very quickly the limitations of modern medicine at treating pain. Doctors and patients have documented that marijuana can offer very effective pain treatment - where other medications have failed - for many patients who suffer from cancer, epilepsy, multiple sclerosis, HIV/AIDS, and other life-threatening or debilitating conditions."

The bill would allow medical use of marijuana under a doctor's supervision, for patients with cancer and other severe debilitating or life-threatening conditions. The bill would set up a tightly regulated and controlled medical marijuana system.

A practitioner who is licensed to prescribe controlled substances could certify that a patient has a severe debilitating or life-threatening condition that can and should be treated with the medical use of marijuana. Certified patients would register with the Health Department. Certifying and dispensing medical marijuana would be included in the I-STOP prescription monitoring system for controlled substances enacted in 2012.